For BlueFocus, AI is no longer a layer of efficiency. It is becoming a test of what kind of company the business can become.
Q4 FY2025 earnings: resilient profits, record wrap account inflows, 11.5% ROE and JPY 64 dividend—plus ORIX Bank deal synergies.
During the pandemic, Firebrick Pharma's (ASX:FRE) anti-infective nasal spray Nasodine seemed a walk-up start for inclusion in ...
The Senate will debate and approve in emergency procedure the draft law L287/2026 on the prohibition of the listing, until ...